Medical treatment in China

CAR-T Cell Therapy

CAR-T is based on the patient's own or, if applicable, donor T cells, which are genetically modified in vitro to obtain a chimeric antigen receptor, commonly targeting CD19 or CD22. Usually, after collection and preparation are completed, a short course of lymphodepleting preconditioning is given,…